Literature DB >> 16756139

[National Program of Early Detection and Prevention of COPD in the years 2000-2002].

Jan Zieliński1, Michał Bednarek, Dorota Górecka.   

Abstract

UNLABELLED: COPD is a highly prevalent disease and ranks 4th among main causes of death in Poland. To control the disease national program of early detection and prevention of COPD was proposed. Program, under the auspices of the Ministry of Health, was implemented by the National TB and Lung Diseases Research Institute in Warsaw and run in out-patient chest clinics all over the country. Smokers aged more than 40 years were proposed a free spirometry and antismoking advice. During three years 91,859 subjects were screened, mean age 53.2 +/- 11.5 years, 57.9% males. There were 61.6% of current smokers, 26.7% of former smokers and 9.7% of never smokers. Spirometric measurements were: in 71.8% normal, in 19.9% showed airflow limitation, and in 8.3 % showed restrictive pattern. Severity of airflow limitation was mild in 7.7%, moderate in 6.7% and severe in 5.6% of all investigated subjects. In smokers older then 40 years and a history of more than 10 pack-years AL was diagnosed in 22,75%. Airflow limitation was found in 14.5% of never smokers. IN
SUMMARY: Program resulted in a very high (20%) diagnosis of airflow limitation. Subjects screened were not aware of their disease. Even subjects who presented with severe form of airflow limitation were not diagnosed earlier.

Entities:  

Mesh:

Year:  2005        PMID: 16756139

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  2 in total

1.  Spirometric screening for COPD: wishful thinking, not evidence.

Authors:  Patrick White
Journal:  Thorax       Date:  2007-08       Impact factor: 9.139

Review 2.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.